| Senolytics |
185 |
16-nov-2026 |
|
| GLP-1 Receptor Agonists |
130 |
16-nov-2026 |
|
| NAD+ Precursors (NR / NMN) |
50 |
10-nov-2026 |
|
| Rapamycin and mTOR Inhibition |
50 |
10-nov-2026 |
|
| Senomorphics |
45 |
13-nov-2026 |
|
| Metformin |
29 |
16-nov-2026 |
|
| Astragalus and TCM Adaptogens |
26 |
16-nov-2026 |
|
| Whey Protein |
24 |
13-nov-2026 |
|
| Quercetin |
24 |
13-nov-2026 |
|
| Vitamin D |
22 |
13-nov-2026 |
|
| Probiotics and Prebiotics (Oral–Brain Axis) |
21 |
13-nov-2026 |
|
| SGLT2 Inhibitors |
21 |
13-nov-2026 |
|
| Resveratrol |
21 |
10-nov-2026 |
|
| Ginsenosides |
20 |
11-oct-2026 |
|
| Sirtuin-1 (SIRT1) and Sirtuins |
19 |
13-nov-2026 |
|
| Dietary (Poly)phenols |
18 |
13-nov-2026 |
|
| Coenzyme Q10 (CoQ10) |
14 |
07-oct-2026 |
|
| Fisetin |
12 |
13-nov-2026 |
|
| Creatine |
9 |
10-nov-2026 |
|
| Urolithin A |
8 |
13-nov-2026 |
|
| Spermidine |
7 |
13-nov-2026 |
|
| ACP Polysaccharides |
6 |
04-oct-2026 |
|
| Omega-3 Fatty Acids (EPA/DHA) |
5 |
10-nov-2026 |
|
| Melatonin |
5 |
07-oct-2026 |
|
| BSH-Active Bifidobacterium (F1-7 / F1-3-2) |
5 |
07-oct-2026 |
|
| HMB (β-Hydroxy β-Methylbutyrate) |
5 |
07-oct-2026 |
|
| N-Acetylcysteine (NAC) |
4 |
11-oct-2026 |
|
| Berberine |
4 |
04-oct-2026 |
|
| EGCG (Epigallocatechin Gallate) |
3 |
28-sep-2026 |
|
| Ergothioneine |
3 |
09-sep-2026 |
|
| Luteolin |
3 |
09-sep-2026 |
|
| Dengzhan Shengmai (DZSM) Formulation |
3 |
09-sep-2026 |
|
| Medicinal Mushrooms |
2 |
16-nov-2026 |
|
| Vitamin C |
2 |
10-nov-2026 |
|
| Testosterone Replacement Therapy (TRT) |
2 |
10-nov-2026 |
|
| Caffeine |
2 |
10-nov-2026 |
|
| Qi-fu-yin (QFY) |
2 |
11-oct-2026 |
|
| Menopause Hormone Therapy |
2 |
07-oct-2026 |
|
| AMPK Activators |
2 |
07-oct-2026 |
|
| Ghrelin |
2 |
07-oct-2026 |
|
| Polygonatum odoratum (Yu Zhu) |
2 |
07-oct-2026 |
|
| Selenium and Selenoproteins |
2 |
07-oct-2026 |
|
| NLRP3 Inflammasome Inhibitors (MCC950) |
2 |
07-oct-2026 |
|
| Lycopene |
2 |
07-oct-2026 |
|
| Statins |
2 |
04-oct-2026 |
|
| Hesperetin (CISD2 Activation) |
2 |
28-sep-2026 |
|
| Ginkgo Biloba Extract |
2 |
10-sep-2026 |
|
| Qinghuang Powder (TCM) |
2 |
10-sep-2026 |
|
| Essential Amino Acids (EAA) |
2 |
10-sep-2026 |
|
| MitoQ (Mitoquinone) |
2 |
10-sep-2026 |
|
| Akkermansia muciniphila and Bioactive Derivatives |
2 |
09-sep-2026 |
|
| Psilocybin |
2 |
09-sep-2026 |
|
| Nicotine |
2 |
09-sep-2026 |
|
| Taurine |
2 |
09-sep-2026 |
|
| L-Carnitine |
2 |
09-sep-2026 |
|
| Alpha-GPC |
2 |
09-sep-2026 |
|
| Citrulline |
2 |
09-sep-2026 |
|
| Fermented Persicaria senegalensis |
1 |
16-nov-2026 |
|
| Placenta-Derived Bioactive Peptides |
1 |
16-nov-2026 |
|
| Cannabinoids (THC / CBD) |
1 |
16-nov-2026 |
|
| Klotho Protein and Gene Therapies |
1 |
16-nov-2026 |
|
| Mitophagy Inducers |
1 |
16-nov-2026 |
|
| LM11A-31 |
1 |
13-nov-2026 |
|
| Elamipretide (SS-31) |
1 |
13-nov-2026 |
|
| GlyNAC (Glycine and N-Acetylcysteine) |
1 |
13-nov-2026 |
|
| Asparagine Endopeptidase (AEP) Inhibitors |
1 |
13-nov-2026 |
|
| Heterophyllin B |
1 |
13-nov-2026 |
|
| Probiotics and Synbiotics for Bone Health |
1 |
10-nov-2026 |
|
| Collagen Peptides and MSM |
1 |
10-nov-2026 |
|
| Nicorandil |
1 |
10-nov-2026 |
|
| Geroprotectors for Neuroprotection and Alzheimer's Prevention |
1 |
10-nov-2026 |
|
| Vanadyl Sulfate |
1 |
10-nov-2026 |
|
| Cepharanthine |
1 |
10-nov-2026 |
|
| Hormetic Geroprotectors |
1 |
10-nov-2026 |
|
| Alpha-Ketoglutarate (AKG) |
1 |
10-nov-2026 |
|
| Bazi Bushen |
1 |
10-nov-2026 |
|
| Donepezil and Cholinergic Enhancement |
1 |
10-nov-2026 |
|
| Cannabigerol (CBG) |
1 |
10-nov-2026 |
|
| Equisetum arvense Polysaccharides |
1 |
10-nov-2026 |
|
| Carotenoids |
1 |
10-nov-2026 |
|
| Dihomo-gamma-linolenic Acid (DGLA) |
1 |
10-nov-2026 |
|
| Thyroid Hormone Receptor Agonists |
1 |
10-nov-2026 |
|
| Pioglitazone |
1 |
10-nov-2026 |
|
| Lysergic Acid Diethylamide (LSD) |
1 |
10-nov-2026 |
|
| Klotho Replacement |
1 |
10-nov-2026 |
|
| Probiotics and Prebiotics |
1 |
18-oct-2026 |
|
| Adropin |
1 |
11-oct-2026 |
|
| Kinetin |
1 |
11-oct-2026 |
|
| PDE4 Inhibitors (Roflumilast / Rolipram) |
1 |
11-oct-2026 |
|
| Galangin |
1 |
07-oct-2026 |
|
| Folate |
1 |
07-oct-2026 |
|
| Vitamin B12 |
1 |
07-oct-2026 |
|
| PeptiStrong (Fava Bean Peptides) |
1 |
07-oct-2026 |
|
| Alpha-Ketoglutarate (AKG) |
1 |
07-oct-2026 |
|
| Vibegron (GEMTESA) |
1 |
07-oct-2026 |
|
| Vicia Faba (Fava Bean) Peptides |
1 |
07-oct-2026 |
|
| Mother-of-Pearl (Nacre) Supplementation |
1 |
07-oct-2026 |
|
| Menopausal Hormone Therapy (Estradiol/HT) |
1 |
07-oct-2026 |
|
| Myostatin Inhibitors |
1 |
07-oct-2026 |
|
| PD-L1 Blockade in the Aging Brain |
1 |
07-oct-2026 |
|
| K21 Antimicrobial |
1 |
07-oct-2026 |
|
| Anti-CXCR3 Therapy |
1 |
07-oct-2026 |
|
| Parthenolide |
1 |
07-oct-2026 |
|
| Elamipretide (SS-31) |
1 |
07-oct-2026 |
|
| β-Hydroxybutyrate (3HB) Supplementation |
1 |
07-oct-2026 |
|
| IL-21R Blockade |
1 |
07-oct-2026 |
|
| Ferrostatin-1 (Fer-1) |
1 |
07-oct-2026 |
|
| Vitamin E and Related Antioxidants |
1 |
07-oct-2026 |
|
| Iron Chelators (Deferoxamine, Deferiprone) |
1 |
07-oct-2026 |
|
| Yashtimadhu (Glycyrrhiza glabra) |
1 |
07-oct-2026 |
|
| Shankhapushpi (Convolvulus pluricaulis) |
1 |
07-oct-2026 |
|
| Guduchi (Tinospora cordifolia) |
1 |
07-oct-2026 |
|
| Bacopa monnieri (Brahmi) |
1 |
07-oct-2026 |
|
| Centella asiatica (Gotu Kola) |
1 |
07-oct-2026 |
|
| Ayurvedic Medhya Rasayanas (Nootropic Rejuvenators) |
1 |
07-oct-2026 |
|
| Ashwagandha (Withania somnifera) |
1 |
07-oct-2026 |
|
| Hypnotics and Z-Drugs (Zolpidem, Zopiclone) |
1 |
07-oct-2026 |
|
| Antihypertensive Therapy and Orthostatic Risk in Aging |
1 |
07-oct-2026 |
|
| NLRP3 Inflammasome Inhibitors |
1 |
07-oct-2026 |
|
| H2S and NO Gasotransmitter Donors |
1 |
07-oct-2026 |
|
| L-Leucine |
1 |
07-oct-2026 |
|
| Naringin |
1 |
07-oct-2026 |
|
| GIP Receptor Agonism and Antagonism |
1 |
07-oct-2026 |
|
| Medium-Chain Triglycerides (MCT) |
1 |
07-oct-2026 |
|
| CMA Activators |
1 |
07-oct-2026 |
|
| PRMT Inhibitors |
1 |
07-oct-2026 |
|
| T1R Sweet Taste Receptor Modulators |
1 |
07-oct-2026 |
|
| Rosiglitazone (PPAR-γ Agonist) |
1 |
05-oct-2026 |
|
| Corni Fructus (Morroniside / Loganin) |
1 |
05-oct-2026 |
|
| MMP9 Neutralization Immunotherapy |
1 |
05-oct-2026 |
|
| IL-11 Neutralizing Antibodies |
1 |
05-oct-2026 |
|
| HDAC Inhibitors (Trichostatin A and related HDACi) |
1 |
05-oct-2026 |
|
| Crocin I |
1 |
05-oct-2026 |
|
| Syringin |
1 |
05-oct-2026 |
|
| Lactate Metabolism and Lactylation Enzyme Modulators |
1 |
05-oct-2026 |
|
| Omega-3 PUFAs (EPA and DHA) |
1 |
05-oct-2026 |
|
| Multi-Micronutrient Repletion (B, C, E, Iron, Selenium, Zinc) |
1 |
05-oct-2026 |
|
| Atorvastatin |
1 |
05-oct-2026 |
|
| Growth Hormone / IGF-1 Axis Modulation |
1 |
05-oct-2026 |
|
| PDK4 Inhibitors |
1 |
05-oct-2026 |
|
| Tofacitinib and JAK Inhibitors |
1 |
05-oct-2026 |
|
| Pectin (Low-Methoxy Pectin) |
1 |
05-oct-2026 |
|
| Dietary Nitrate (Beetroot Juice) |
1 |
04-oct-2026 |
|
| Omega-3 Polyunsaturated Fatty Acids (n-3 PUFAs) |
1 |
04-oct-2026 |
|
| Hydrolyzed Cricket Protein |
1 |
04-oct-2026 |
|
| Silicate Bioceramics (Silicate Anti-Senescence / ZnCS) |
1 |
04-oct-2026 |
|
| Taxifolin–Zinc Nanozyme (SOD-Mimetic) |
1 |
04-oct-2026 |
|
| Opicapone (COMT Inhibitor) |
1 |
04-oct-2026 |
|
| Medium-Chain Triglycerides (MCTs) |
1 |
04-oct-2026 |
|
| Perilla frutescens Extract (EAEPF) |
1 |
04-oct-2026 |
|
| uPAR-Targeting Bispecific T-Cell Engager (GFD-CD3) Senolytic |
1 |
04-oct-2026 |
|
| Dual Orexin Receptor Antagonists (DORAs) |
1 |
04-oct-2026 |
|
| Ginseng–Schisandra Co-Decoction (TG) |
1 |
04-oct-2026 |
|
| Dendrobium officinale (Tiepi Shihu) |
1 |
28-sep-2026 |
|
| Polygonatum (Huangjing) |
1 |
28-sep-2026 |
|
| Zuogui Pill (ZGP) |
1 |
28-sep-2026 |
|
| Parishin B (Gastrodia elata) |
1 |
28-sep-2026 |
|
| Intravenous Immunoglobulin (IVIg) |
1 |
28-sep-2026 |
|
| Human Albumin (Plasma Therapy) |
1 |
28-sep-2026 |
|
| Omega-3 Fish Oil |
1 |
28-sep-2026 |
|
| RANKL Inhibitors (Denosumab) |
1 |
28-sep-2026 |
|
| Denosumab (RANK-Ligand Inhibition) |
1 |
28-sep-2026 |
|
| Oral Collagen Peptides |
1 |
28-sep-2026 |
|
| Calcium Alpha-Ketoglutarate (CaAKG) |
1 |
28-sep-2026 |
|
| Angiotensin-(1-7) |
1 |
28-sep-2026 |
|
| Specialized Pro-Resolving Mediators (SPMs) |
1 |
28-sep-2026 |
|
| LDL-Lowering Therapies for Prevention |
1 |
28-sep-2026 |
|
| Thyroid Hormone Therapy (T4/T3) |
1 |
28-sep-2026 |
|
| Adiponectin Receptor Agonists |
1 |
28-sep-2026 |
|
| BIRC6 Inhibition (LNP-ASO) |
1 |
28-sep-2026 |
|
| SUMO Pathway Modulators (TAK-981, SENP Modulators) |
1 |
28-sep-2026 |
|
| AICAR and Pharmacologic AMPK Agonists |
1 |
28-sep-2026 |
|
| Hepassocin (HPS) |
1 |
28-sep-2026 |
|
| AEP Inhibitors (CP#11A) |
1 |
28-sep-2026 |
|
| ZFP423 Antisense Oligonucleotide (Adipose Thermogenesis) |
1 |
28-sep-2026 |
|
| Wheat Germ Bioactive Peptides |
1 |
28-sep-2026 |
|
| Cross-Species Geroprotector Screening |
1 |
28-sep-2026 |
|
| K21 (Silane Derivative) |
1 |
28-sep-2026 |
|
| Heme Oxygenase-1 (HO-1) Modulation |
1 |
28-sep-2026 |
|
| KIF11 Inhibitors (Cardiac Autophagy) |
1 |
28-sep-2026 |
|
| Mitochonic Acid-5 (MA-5) |
1 |
28-sep-2026 |
|
| cis P-tau Immunotherapy |
1 |
28-sep-2026 |
|
| Antioxidant Interventions for Aging-Related Muscle Decline |
1 |
28-sep-2026 |
|
| Astaxanthin |
1 |
28-sep-2026 |
|
| Growth Hormone (GH) |
1 |
28-sep-2026 |
|
| Molecular Hydrogen (H2) |
1 |
28-sep-2026 |
|
| LSD1 Inhibitors |
1 |
28-sep-2026 |
|
| Schisandra chinensis (Schisandrae Fructus) |
1 |
27-sep-2026 |
|
| 4-Octyl Itaconate Engineered Extracellular Vesicles (4OI-EVs) |
1 |
27-sep-2026 |
|
| Algal Bioactives |
1 |
27-sep-2026 |
|
| Lysine Supplementation |
1 |
27-sep-2026 |
|
| Jintiange (Artificial Tiger Bone) |
1 |
27-sep-2026 |
|
| P7C3 (NAMPT Activator) |
1 |
27-sep-2026 |
|
| Potentially Inappropriate Medications (PIM) in Older Adults |
1 |
27-sep-2026 |
|
| Cytokine-Targeted Biologics (IL-1β, IL-6, TNF-α) |
1 |
27-sep-2026 |
|
| CD38 Inhibitors |
1 |
27-sep-2026 |
|
| Leucine-Enriched Essential Amino Acids (LEAA) |
1 |
27-sep-2026 |
|
| Imeglimin |
1 |
20-sep-2026 |
|
| Silibinin (Milk Thistle) |
1 |
20-sep-2026 |
|
| EN001 |
1 |
13-sep-2026 |
|
| Lumateperone |
1 |
13-sep-2026 |
|
| Antifibrotic Lung Drugs |
1 |
13-sep-2026 |
|
| Mitochondria-Targeted Esculetin (Mito-Esc) |
1 |
13-sep-2026 |
|
| C3a–C3AR1 Pathway Inhibitors |
1 |
13-sep-2026 |
|
| Influenza Vaccination (Heterologous Longevity Effects) |
1 |
13-sep-2026 |
|
| PD-L2 Checkpoint Blockade |
1 |
13-sep-2026 |
|
| Myostatin/Activin Pathway Inhibitors |
1 |
13-sep-2026 |
|
| Selective Androgen Receptor Modulators (SARMs) |
1 |
13-sep-2026 |
|
| Ghrelin Mimetics and Appetite-Directed Therapies |
1 |
13-sep-2026 |
|
| Mitochondria-Targeted Muscle Therapeutics |
1 |
13-sep-2026 |
|
| Branched-Chain Amino Acids (BCAAs) |
1 |
13-sep-2026 |
|
| SUMO Enzyme Modulators |
1 |
13-sep-2026 |
|
| Mdivi-1 and Mitochondrial Fission Inhibitors |
1 |
13-sep-2026 |
|
| Mitochondria-Targeted Antioxidants (MitoQ, SkQ1) |
1 |
13-sep-2026 |
|
| Alloprevotella rava |
1 |
10-sep-2026 |
|
| Cinnamon Polysaccharides |
1 |
10-sep-2026 |
|
| Sodium Danshensu (Danshen / Salvia miltiorrhiza) |
1 |
10-sep-2026 |
|
| Asiaticoside |
1 |
10-sep-2026 |
|
| Pearl Powder |
1 |
10-sep-2026 |
|
| Chinese Yam (Dioscorea polystachya) |
1 |
10-sep-2026 |
|
| Armillariella tabescens Polysaccharide (ATEP) |
1 |
10-sep-2026 |
|
| Heidihuang Pill (HDHW) |
1 |
10-sep-2026 |
|
| Du-Shu-Wan (DSW) |
1 |
10-sep-2026 |
|
| β-Glucan (Aureobasidium pullulans) |
1 |
10-sep-2026 |
|
| Pentadecanoic Acid (C15:0) |
1 |
10-sep-2026 |
|
| Ketone Monoester Supplementation |
1 |
10-sep-2026 |
|
| Ketone Esters |
1 |
10-sep-2026 |
|
| Lamivudine (3TC) |
1 |
10-sep-2026 |
|
| Glycine |
1 |
10-sep-2026 |
|
| LpD3.5 Postbiotic |
1 |
10-sep-2026 |
|
| Anticholinergic Exposure and Cognitive Risk |
1 |
10-sep-2026 |
|
| FMO1 Inhibitors |
1 |
10-sep-2026 |
|
| Lonafarnib (Farnesyltransferase Inhibition) |
1 |
10-sep-2026 |
|
| MMP7-Targeted Antifibrotic Candidates (Marimastat, Pirfenidone, OCA) |
1 |
10-sep-2026 |
|
| TWEAK/Fn14 Targeting |
1 |
10-sep-2026 |
|
| Buriti-Based Vegan Protein (Nutricer) |
1 |
09-sep-2026 |
|
| Shanyu Pill |
1 |
09-sep-2026 |
|
| Oral Nutritional Supplements (ONS) |
1 |
09-sep-2026 |
|
| Ursolic Acid (Apple Pomace) |
1 |
09-sep-2026 |
|
| Major Ozone Autohemotherapy |
1 |
09-sep-2026 |
|
| Polyphenol Supplementation |
1 |
09-sep-2026 |
|
| TJ0113 Capsule |
1 |
09-sep-2026 |
|
| AAV-Follistatin Gene Therapy |
1 |
09-sep-2026 |
|
| Leucine-Enriched Nutrition |
1 |
09-sep-2026 |
|
| Ketosteril (Ketoanalogues) |
1 |
09-sep-2026 |
|
| IN-207907 Injection for Sarcopenia |
1 |
09-sep-2026 |
|
| AMC6156 |
1 |
09-sep-2026 |
|
| Exogenous Lactate |
1 |
09-sep-2026 |
|
| Miricell |
1 |
09-sep-2026 |
|
| Autophagy (intervention target) |
1 |
09-sep-2026 |
|
| Apple Extract (AppleX) |
1 |
09-sep-2026 |
|
| Dietary Nitrate Supplementation |
1 |
09-sep-2026 |
|
| Polypharmacy and Potentially Inappropriate Prescribing in Aging |
1 |
09-sep-2026 |
|
| Acetate (Short-Chain Fatty Acid) |
1 |
09-sep-2026 |
|
| Exogenous Ketones (Ketone Monoesters) |
1 |
09-sep-2026 |
|
| Cannabidiol (CBD) |
1 |
09-sep-2026 |
|
| Beta3-Adrenergic Receptor Targeting |
1 |
09-sep-2026 |
|
| Multivitamin and Mineral (MVM) Supplementation |
1 |
09-sep-2026 |
|
| Rentosertib |
1 |
09-sep-2026 |
|
| Testosterone Replacement Therapy (TRT) |
1 |
09-sep-2026 |
|
| AI-Generated Aging Drug Candidates |
1 |
09-sep-2026 |
|
| Fadogia Agrestis |
1 |
09-sep-2026 |
|
| Boron |
1 |
09-sep-2026 |
|
| Betaine |
1 |
09-sep-2026 |
|
| Tongkat Ali (Longjack) |
1 |
09-sep-2026 |
|
| CoQ10 (Coenzyme Q10) |
1 |
09-sep-2026 |
|
| Huperzine A |
1 |
09-sep-2026 |
|
| Myo-Inositol |
1 |
09-sep-2026 |
|
| L-Tyrosine |
1 |
09-sep-2026 |
|
| Mucuna Pruriens |
1 |
09-sep-2026 |
|
| Phenethylamine (PEA) |
1 |
09-sep-2026 |
|
| Oral Contraceptives and Female Hormone Health |
1 |
09-sep-2026 |
|
| Magnesium |
1 |
09-sep-2026 |
|
| Lithium |
1 |
09-sep-2026 |
|
| Peptides |
1 |
09-sep-2026 |
|
| Vaginal Estrogen (Local Estrogen Therapy) |
1 |
09-sep-2026 |
|
| Growth Hormone Receptor Inhibition |
1 |
09-sep-2026 |
|
| Bisphosphonates and Aging |
1 |
09-sep-2026 |
|
| Piezo1 Agonists |
1 |
09-sep-2026 |
|
| Growth Hormone Receptor Antagonists |
1 |
09-sep-2026 |
|
| Rhododendron Pachypodum Iridoids |
1 |
09-sep-2026 |
|
| Broad-Spectrum Antioxidants |
1 |
09-sep-2026 |
|
| Tubeimoside I (TBMS1) |
1 |
09-sep-2026 |
|
| Dietary Geroprotective Peptides |
1 |
09-sep-2026 |
|
| CAR T Cell Senolytic Therapy |
1 |
09-sep-2026 |
|
| Procyanidin C1 (PCC1) and NSPCC1 |
1 |
09-sep-2026 |
animal-only
|
| mPGES-2 Inhibitors (SZ0232) |
1 |
09-sep-2026 |
|
| Magnetospirillum magneticum AMB-1 |
1 |
09-sep-2026 |
|
| Verteporfin (YAP1/TEAD Inhibition) |
1 |
09-sep-2026 |
|
| ASO Therapy Targeting LMNA/Progerin |
1 |
09-sep-2026 |
|
| Multivitamin-Multimineral |
1 |
09-sep-2026 |
|
| Fucoidan |
1 |
09-sep-2026 |
|
| MC1 (Melatonin–Catechol Hybrid) |
1 |
09-sep-2026 |
|
| Jujuboside A |
1 |
09-sep-2026 |
|
| cGAS-Targeting Therapeutics (siRNA / Interface Peptides) |
1 |
09-sep-2026 |
|
| MSC-Derived Exosomes for Ovarian Aging |
1 |
09-sep-2026 |
|
| Ammonia-Lowering Agents |
1 |
09-sep-2026 |
|
| Sea Buckthorn Flavonoid IGRh (Isorhamnetin Glycoside) |
1 |
09-sep-2026 |
|
| Ruxolitinib (JAK Inhibition) |
1 |
09-sep-2026 |
|
| Syringaresinol |
1 |
09-sep-2026 |
|
| Complement Inhibitors (Intracellular/Complosome-Targeted) |
1 |
09-sep-2026 |
|
| Immuno-senolytics |
1 |
09-sep-2026 |
|
| Denosumab (RANKL Inhibition) |
1 |
09-sep-2026 |
|
| Isoliquiritigenin |
1 |
09-sep-2026 |
|
| SIRT6 Activators (MDL-800) |
1 |
09-sep-2026 |
|
| Glycitein |
1 |
09-sep-2026 |
|
| Azelaic Acid |
1 |
09-sep-2026 |
|
| Bifidobacterium pseudocatenulatum |
1 |
09-sep-2026 |
|
| 5-Aminovaleric Acid Betaine (5-AVAB) |
1 |
09-sep-2026 |
|
| Lycii Fructus Polysaccharide (FSP) |
1 |
09-sep-2026 |
|
| Cocoa Polyphenols |
1 |
09-sep-2026 |
|
| Repurposable Drugs and Targets for Premature Ovarian Insufficiency |
1 |
09-sep-2026 |
|
| EPHA4 Targeting in Ovarian Aging / POI |
1 |
09-sep-2026 |
|
| FSTL3 in Ovarian Aging / POI |
1 |
09-sep-2026 |
|
| NUCB2 in Ovarian Aging / POI |
1 |
09-sep-2026 |
|
| L-Glutamine Supplementation |
1 |
09-sep-2026 |
|
| DNA Methyltransferase (DNMT) Inhibitors |
1 |
09-sep-2026 |
|
| CRISPR/dCas Epigenetic Editing |
1 |
09-sep-2026 |
|
| Egg-Derived Peptides (American Shad) |
1 |
09-sep-2026 |
|
| STING Inhibitors (H-151) |
1 |
09-sep-2026 |
|
| AAP50-2 Homogalacturonan (Anemarrhena asphodeloides) |
1 |
09-sep-2026 |
|
| SIRT6 Gene Delivery (AAV) |
1 |
09-sep-2026 |
|
| Fucoidan (Fucoidan-FV) SIRT6 Activation |
1 |
09-sep-2026 |
|
| Apelin |
1 |
09-sep-2026 |
|
| Oxytocin |
1 |
09-sep-2026 |
|
| Superoxide Dismutase (SOD) |
1 |
09-sep-2026 |
|
| Fostamatinib (SYK Inhibition) |
1 |
09-sep-2026 |
|
| Ropsacitinib (TYK2 Inhibition) |
1 |
09-sep-2026 |
|
| HIF-1α/BNIP3 Pharmacological MSC Rejuvenation |
1 |
09-sep-2026 |
|
| USP30 Inhibitors |
1 |
09-sep-2026 |
|
| Parkin Molecular Glue Activators |
1 |
09-sep-2026 |
|
| ClpP-Based Mitochondria-Targeted PROTACs |
1 |
09-sep-2026 |
|
| Anthocyanins |
1 |
09-sep-2026 |
|
| Bofutsushosan (BTS) |
1 |
09-sep-2026 |
|
| HMGCR Inhibitors (Statins and Targeted Blockade) |
1 |
09-sep-2026 |
|
| Polygonatum sibiricum Polysaccharide (PSP) |
1 |
09-sep-2026 |
|
| Estrogen and HRT for Menopausal Aging |
1 |
09-sep-2026 |
|
| NP-2007 Low-MW Collagen Hydrolysate |
1 |
09-sep-2026 |
|
| Chlorella Hot Water Extract (CHWE) |
1 |
09-sep-2026 |
|
| Silkworm Pupa Protein Hydrolysate (SPPH) and FKVPNM |
1 |
09-sep-2026 |
|
| Oleic Acid |
1 |
09-sep-2026 |
|
| Lactiplantibacillus plantarum |
1 |
09-sep-2026 |
|
| Kimchi Probiotic Wikim0187 |
1 |
09-sep-2026 |
|
| Lycium barbarum Polysaccharide (LBP) |
1 |
09-sep-2026 |
|
| Filbertone |
1 |
09-sep-2026 |
|
| Porcine Whole-Blood Protein Hydrolysate (PWBPH) |
1 |
09-sep-2026 |
|
| FXR/TGR5 Agonists |
1 |
09-sep-2026 |
|
| Ginseng and Codonopsis Polysaccharides (GPF-2 / CPF-2) |
1 |
09-sep-2026 |
|
| Diosgenin |
1 |
09-sep-2026 |
|
| Nebivolol |
1 |
09-sep-2026 |
|
| Dioscin |
1 |
09-sep-2026 |
|
| Intra-Articular Corticosteroids for Joint Aging |
1 |
09-sep-2026 |
|
| Hyaluronic Acid (Intra-Articular) |
1 |
09-sep-2026 |
|
| Platelet-Rich Plasma (PRP) |
1 |
09-sep-2026 |
|
| Mesenchymal Stromal/Stem Cell Joint Therapies |
1 |
09-sep-2026 |
|
| Benzodiazepines and Iatrogenic Aging |
1 |
09-sep-2026 |
|
| Pentadecanoic Acid (C15:0) |
1 |
09-sep-2026 |
|
| PRMT6 Inhibitors (EPZ020411) |
1 |
09-sep-2026 |
|
| TIMP2 (Tissue Inhibitor of Metalloproteinases 2) |
1 |
09-sep-2026 |
|
| Betulinic Acid |
1 |
09-sep-2026 |
|
| EGCG (Green Tea Catechin) |
1 |
09-sep-2026 |
|
| Botanical Extracts for Sarcopenia |
1 |
09-sep-2026 |
|
| Phycocyanobilin (PCB) |
1 |
09-sep-2026 |
|
| Selenium and Selenoproteins |
1 |
09-sep-2026 |
|
| Lactiplantibacillus plantarum AS21 |
1 |
09-sep-2026 |
|
| ANGPTL8 Inhibition |
1 |
09-sep-2026 |
|
| Proanthocyanidins |
1 |
09-sep-2026 |
|
| Zinc |
1 |
09-sep-2026 |
|
| Curcumin |
1 |
09-sep-2026 |
|
| Shashen Maidong Decoction (SMD) |
1 |
09-sep-2026 |
|
| Dextromethorphan Glutamatergic Adjuncts |
1 |
08-sep-2026 |
|
| Melanocortin-4 Receptor Agonists |
1 |
08-sep-2026 |
|
| TXNIP Inhibitors (e.g. SRI-37330) |
1 |
08-sep-2026 |
|
| Omega-3 Fatty Acids |
0 |
08-sep-2026 |
awaiting-synthesis
|